EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeted next-generation sequencing - a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance

Xiaocui Wu, Guangkun Tan, Chunlei Sun, Yang Wang, Jinghui Yang, Chunqiu Wu, Chaohui Hu, Fangyou Yu

Infection · 2025-06 · 53 (3) · 967-979

DOI: 10.1007/s15010-024-02411-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, online erschienen am 17.10.2024. Verfasst von Xiaocui Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, High-Throughput Nucleotide Sequencing, Drug Resistance, Bacterial, Tuberculosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Health Commission's Special Youth Project for Clinical Research in the Health Industry, Shanghai Three-year (2023-2025) Action Plan to Strengthen the Public Health System, Shanghai Science and Technology Innovation Action Plan, Medical Innovation Research Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisHigh-Throughput Nucleotide SequencingDrug Resistance, BacterialTuberculosisTuberculosis, Multidrug-ResistantHumansMicrobial Sensitivity TestsAntitubercular AgentsBronchoalveolar Lavage FluidMaleWhole Genome SequencingFemaleAdult

Stichwörter der Autor:innen

Mycobacterium tuberculosisDiagnosisDrug resistanceTargeted next-generation sequencing

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Clinical Laboratory, Shanghai University of Traditional Chinese Medical Attached Shuguang Hospital, Shanghai, China.
  • Department of Clinical Laboratory, Shanghai Eye Disease Prevention & Treatment Center, Shanghai Eye Hospital, Shanghai, China.
  • Guangzhou KingCreate Biotechnology Co., Ltd., Guangzhou, China.
  • Guangzhou KingCreate Biotechnology Co., Ltd., Guangzhou, China. huzh@kingcreate.com.cn.

Förderung

  • Shanghai Municipal Health Commission's Special Youth Project for Clinical Research in the Health Industry
  • Shanghai Three-year (2023-2025) Action Plan to Strengthen the Public Health System
  • Shanghai Science and Technology Innovation Action Plan, Medical Innovation Research Special Project

Zitieren

APA

Wu, X., Tan, G., Sun, C., Wang, Y., Yang, J., Wu, C., Hu, C., & Yu, F. (2025). Targeted next-generation sequencing - a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance. Infection, 53(3), 967-979. https://doi.org/10.1007/s15010-024-02411-w

Vancouver

Wu X, Tan G, Sun C, Wang Y, Yang J, Wu C, et al. Targeted next-generation sequencing - a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance. Infection. 2025;53(3):967-979. doi:10.1007/s15010-024-02411-w

BibTeX
@article{Wu2025,
  author = {Wu, Xiaocui and Tan, Guangkun and Sun, Chunlei and Wang, Yang and Yang, Jinghui and Wu, Chunqiu and Hu, Chaohui and Yu, Fangyou},
  title = {Targeted next-generation sequencing - a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance},
  journal = {Infection},
  year = {2025},
  volume = {53},
  number = {3},
  pages = {967--979},
  doi = {10.1007/s15010-024-02411-w}
}
Kostenlos starten →